Home›Compare›WellMaleRx vs Yucca Health

WellMaleRx vs Yucca Health: Which Is Better?

Head-to-head comparison of WellMaleRx and Yucca Health based on our independent scoring across trust, value, experience, product range, and reputation — plus real pricing for the treatments they both offer.

Our Verdict

Yucca Health scores higher overall in our independent evaluation (68.3/100 vs 55/100), leading on trust & safety, value, experience, reputation. WellMaleRx comes out ahead on product range. WellMaleRx has the lower entry price (from $76.99/mo vs $125/mo), so the better value depends on which treatment you need.

WellMaleRx is a new compounded-medication telehealth storefront offering seven multi-ingredient ED formulas (including 'Overdrive Plus') and nine NAD+, glutathione and MIC/B12 longevity products.

Visit WellMaleRx

Yucca Health is a Beverly Hills-based telehealth platform selling compounded semaglutide and tirzepatide at flat, dose-independent prices, plus compounded NAD+ and sermorelin.

Visit Yucca Health

Score Breakdown

DimensionWellMaleRxYucca Health
Overall Score55/10068.3/100 ✓
Trust & Safety30%50/10064/100 ✓
Value25%64/10080/100 ✓
Experience20%55/10072/100 ✓
Product Range15%60/100 ✓58/100
Reputation10%40/10060/100 ✓

At a Glance

Founded20262025
Headquarters—Beverly Hills, CA
Publicly tradedNoNo
Treatment categories32
Treatments listed74
Starting price$76.99/mo$125/mo

Pricing Where They Compete

Prices shown are based on our most recent research and may not reflect current pricing. Telehealth providers update their pricing frequently. Always verify pricing directly with the provider before purchasing.

CategoryWellMaleRxYucca Health
Longevity & Peptides$79.5–$159
Lipolean (MIC/B12)
$158–$215
NAD+ Injection

WellMaleRx

+Per-pack and per-dose pricing is published for every formula before intake
+Wide compounded ED range (seven formulas incl. bremelanotide and apomorphine combinations) plus NAD+ and glutathione in injectable, nasal and patch forms
+States one-click pause, skip or cancel from the patient dashboard with no cancellation fee
−No operating company, founders, medical group or pharmacy is named anywhere on the site
−$40 consultation fee is charged when an intake is declined or incomplete
−Advertised first-order prices are intro rates; refills bill at a higher 'member rate' (e.g. NAD+ $99.50 first month, then $199/month)
Read the full WellMaleRx review →

Yucca Health

+Full price grid published before intake: semaglutide $146/mo monthly, $140/mo quarterly or $125/mo on a 6-month prepay; tirzepatide $258, $248 or $225/mo
+Locked pricing covers the whole dose range, so titrating up does not raise the bill; pausing keeps the locked rate
+No separate membership or consultation fee; plans include the provider consult, medication, injection supplies and free 2-day shipping
−Dispensing pharmacies are not named on the public site; they appear only in the patient portal and on the label after ordering
−BBB rating of C+ (not accredited) with five closed complaints; one Trustpilot reviewer reports prepaying six months and receiving three
−About 6% of roughly 1,230 Trustpilot reviews are 1-star, citing lack of results after months of treatment and refund disputes
Read the full Yucca Health review →

WellMaleRx vs Yucca Health — FAQ

Is WellMaleRx better than Yucca Health?

▾

Yucca Health scores higher overall in our independent evaluation (68.3/100 vs 55/100), leading on trust & safety, value, experience, reputation. WellMaleRx comes out ahead on product range. WellMaleRx has the lower entry price (from $76.99/mo vs $125/mo), so the better value depends on which treatment you need.

Is WellMaleRx or Yucca Health cheaper?

▾

WellMaleRx has the lower starting price (from $76.99/mo vs $125/mo for Yucca Health). Starting prices are for the cheapest treatment each offers — compare the specific treatment you need, and check what each price includes.

What do WellMaleRx and Yucca Health both offer?

▾

Both platforms treat Longevity & Peptides. WellMaleRx covers 3 treatment categories total and Yucca Health covers 2.

Still deciding?